News
Prime Global and Raremark form strategic partnership to transform solutions and outcomes for patients with rare diseases
Medical communications company, Prime Global, and healthcare technology company, Raremark®, announced that they have formed a strategic partnership to transform solutions for patients with...
News
Elasmogen identifies potential vaccine candidates to fight Covid-19
Elasmogen Ltd, the pioneering biopharmaceutical company leading the development of VNAR and soloMERTM biologics, announces a significant breakthrough in the identification of next-generation protein-based...
News
Mundipharma and Cidara’s rezafungin gets Orphan Drug Designation in EU
The European Commission (EC) has adopted the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) recommendation to grant Orphan Drug Designation (ODD)...
Drug Research
Humanetics receives US DoD funding for Covid-19 drug development
Humanetics has received funding from the US Department of Defense (DoD) to carry out a series of studies with its novel drug candidate, BIO...
News
Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab with VIR-7831
Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced a collaboration to evaluate a combination of two COVID-19 therapies in low-risk patients...
News
Moderna Confirms Discussions with U.S. Government for Additional 100 Million Doses of the Moderna COVID-19 Vaccine
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines confirmed that the Company is in discussion with the U.S. government to...
Press Releases
BC Platforms, RIKEN and the Finnish Institute for Health and Welfare collaborate on AI approach to identify people most at risk of from COVID-19
BC Platforms, a global leader in clinical and genomic data management, analytics and access, announces that it has joined forces with Japan’s RIKEN research...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read